Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-25-331162

Chief Financial Officer sold 10,000 shares at an average $55.95 ($559,549)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Prasad Raju · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-22 Sale : show line 1 in the form 10b5-1 −3,528 $55.10 $194,401 13,239 D
2025-12-22 Sale : show line 2 in the form 10b5-1 −5,472 $56.33 $308,262 7,767 D
2025-12-22 Sale : show line 3 in the form 10b5-1 −1,000 $56.89 $56,886 6,767 D
Open-market sales · 10,000 sh · avg $55.95 · $559,549
Loading xslF345X05/ownership.xml…